APA

Brain E., Garrino C., Misset J. L., Carbonero I. G., Itzhaki M., Cvitkovic E., Goldschmidt E., Burki F., Regensberg C., Pappo E., Hagipantelli R. & Musset M. (19970605). Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. : British journal of cancer.

Chicago

Brain E, Garrino C, Misset J L, Carbonero I G, Itzhaki M, Cvitkovic E, Goldschmidt E, Burki F, Regensberg C, Pappo E, Hagipantelli R and Musset M. 19970605. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. : British journal of cancer.

Harvard

Brain E., Garrino C., Misset J. L., Carbonero I. G., Itzhaki M., Cvitkovic E., Goldschmidt E., Burki F., Regensberg C., Pappo E., Hagipantelli R. and Musset M. (19970605). Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. : British journal of cancer.

MLA

Brain E, Garrino C, Misset J L, Carbonero I G, Itzhaki M, Cvitkovic E, Goldschmidt E, Burki F, Regensberg C, Pappo E, Hagipantelli R and Musset M. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. : British journal of cancer. 19970605.